IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q1 2026 Holdings

Filed 2026-05-14 | 3 holdings | $1.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc(TCRX)COM89854M101$630.0K630,00042.4%
Werewolf Therapeutics Inc(HOWL)COM95075A107$490.5K589,10233.0%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$365.4K642,20424.6%